Table 2 Demographics and clinical characteristics of CLD patients awaiting liver transplant scored as A, B, or C using the Child-Turcotte-Pugh scoring system (CTP-A, CTP-B, or CTP-C)

Age

59.5 (56.5–61.5)

59 (52–65)

55 (41–69)

Sex [n (%)]

 Male

11 (92)

18 (64)

3 (100)

 Female

1 (8)

10 (36)

0 (0)

Race (n)

 White

11

27

3

 Black

0

1

0

 Other

1

0

0

Etiology (n)

 ASH

7

10

2

 NASH

7

16

1

 HCV

6

2

1

 Mixed liver disease

8

3

1

 Portal vein thrombosis

1

2

1

MELD-Na score

10 (9–12)

15 (11–17)

19 (16–20)

Serum sodium

139 (138–140)

137 (135–138)

138 (134–139)

Serum creatinine

0.79 (0.73–1.26)

0.91 (0.71–1.23)

1.02 (0.79–1.12)

Total bilirubin

1.1 (0.7–1.4)

1.9 (1.3–2.7)

5.2 (2.4–6.9)

PT/INR

1.2 (1.1–1.3)

1.4 (1.2–1.5)

1.6 (1.5–1.7)

Serum albumin

3.8 (3.7–3.9)

3.4 (3.2–3.7)

2.5 (2.5–3.2)

FV (%)

79 (66–100)

65 (45–81)

40 (39–44)

FVIII (%)

259 (215–278)

253 (193–312)

233 (227–291)

PC (%)

66 (48–84)

53 (35–63)

22 (21–41)

PS (%)

59 (47–76)

59 (50–67)

66 (61–69)

D-Di (ng/m)

0.85 (0.54–1.36)

2.94 (1.52–6.56)

3.50 (2.20–9.61)

sP selectin (pg/m)

43 (39–47)

57 (41–67)

49 (39–71)

asTF (ng/m)

1.011 (0.445–2.503)

0.456 (0.333–0.986)

0.133, 0.254**

Novel CLD score

11.2 (9.4–12.8)

14.8 (12.5–18.3)

21.8 (21.3–22.5)